152 related articles for article (PubMed ID: 26463869)
1. A Prospective Multicenter Study Evaluating Secondary Adrenal Suppression After Antiemetic Dexamethasone Therapy in Cancer Patients Receiving Chemotherapy: A Korean South West Oncology Group Study.
Han HS; Park JC; Park SY; Lee KT; Bae SB; Kim HJ; Kim S; Yun HJ; Bae WK; Shim HJ; Hwang JE; Cho SH; Park MR; Shim H; Kwon J; Choi MK; Kim ST; Lee KH
Oncologist; 2015 Dec; 20(12):1432-9. PubMed ID: 26463869
[TBL] [Abstract][Full Text] [Related]
2. A pilot study of adrenal suppression after dexamethasone therapy as an antiemetic in cancer patients.
Han HS; Shim YK; Kim JE; Jeon HJ; Lim SN; Oh TK; Lee KH; Kim ST
Support Care Cancer; 2012 Jul; 20(7):1565-72. PubMed ID: 21850416
[TBL] [Abstract][Full Text] [Related]
3. A Pilot Study Evaluating Steroid-Induced Diabetes after Antiemetic Dexamethasone Therapy in Chemotherapy-Treated Cancer Patients.
Jeong Y; Han HS; Lee HD; Yang J; Jeong J; Choi MK; Kwon J; Jeon HJ; Oh TK; Lee KH; Kim ST
Cancer Res Treat; 2016 Oct; 48(4):1429-1437. PubMed ID: 26987397
[TBL] [Abstract][Full Text] [Related]
4. Association between megestrol acetate treatment and symptomatic adrenal insufficiency with hypogonadism in male patients with cancer.
Dev R; Del Fabbro E; Bruera E
Cancer; 2007 Sep; 110(6):1173-7. PubMed ID: 17647248
[TBL] [Abstract][Full Text] [Related]
5. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
6. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C
Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting over multiple cycles of moderately or highly emetogenic chemotherapy.
Rapoport B; Schwartzberg L; Chasen M; Powers D; Arora S; Navari R; Schnadig I
Eur J Cancer; 2016 Apr; 57():23-30. PubMed ID: 26851398
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.
Chiou TJ; Tzeng WF; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429
[TBL] [Abstract][Full Text] [Related]
9. A low-dose adrenocorticotropin test reveals impaired adrenal function in cancer patients receiving megestrol acetate therapy.
Ron IG; Soyfer V; Goldray D; Inbar MJ; Weisman Y
Eur J Cancer; 2002 Jul; 38(11):1490-4. PubMed ID: 12110495
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer.
Italian Group for Antiemetic Research
N Engl J Med; 1995 Jan; 332(1):1-5. PubMed ID: 7990859
[TBL] [Abstract][Full Text] [Related]
11. Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.
Einaudi S; Bertorello N; Masera N; Farinasso L; Barisone E; Rizzari C; Corrias A; Villa A; Riva F; Saracco P; Pastore G
Pediatr Blood Cancer; 2008 Mar; 50(3):537-41. PubMed ID: 17828747
[TBL] [Abstract][Full Text] [Related]
12. Acute Adrenal Insufficiency After an Antiemetic Dose of Dexamethasone: A Case Report.
Bacigalupo Landa A; Viswanath O; D'Mello J
A A Pract; 2019 Jun; 12(11):424-425. PubMed ID: 30633007
[TBL] [Abstract][Full Text] [Related]
13. Adrenal function following high-dose steroids in ovarian cancer patients.
Del Priore G; Gurski KJ; Warshal DP; Angel C; Dubeshter B
Gynecol Oncol; 1995 Oct; 59(1):102-4. PubMed ID: 7557593
[TBL] [Abstract][Full Text] [Related]
14. Incidence of chemotherapy-induced nausea and vomiting associated with docetaxel and cyclophosphamide in early breast cancer patients and aprepitant efficacy as salvage therapy. Results from the Spanish Breast Cancer Group/2009-02 study.
Llombart-Cussac A; Ramos M; Dalmau E; García-Saenz JA; González-Farré X; Murillo L; Calvo L; Morales S; Carañana V; González A; Fernández-Morales LA; Moreno F; Casas MI; Angulo Mdel M; Cámara MC; Garcia-Mace AI; Carrasco E; Jara-Sánchez C
Eur J Cancer; 2016 May; 58():122-9. PubMed ID: 26994459
[TBL] [Abstract][Full Text] [Related]
15. Aprepitant plus palonosetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy.
Gao HF; Liang Y; Zhou NN; Zhang DS; Wu HY
Intern Med J; 2013 Jan; 43(1):73-6. PubMed ID: 22141732
[TBL] [Abstract][Full Text] [Related]
16. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
de Wit R; Herrstedt J; Rapoport B; Carides AD; Guoguang-Ma J; Elmer M; Schmidt C; Evans JK; Horgan KJ
Eur J Cancer; 2004 Feb; 40(3):403-10. PubMed ID: 14746859
[TBL] [Abstract][Full Text] [Related]
17. Antiemetic Corticosteroid Rotation from Dexamethasone to Methylprednisolone to Prevent Dexamethasone-Induced Hiccup in Cancer Patients Treated with Chemotherapy: A Randomized, Single-Blind, Crossover Phase III Trial.
Go SI; Koo DH; Kim ST; Song HN; Kim RB; Jang JS; Oh SY; Lee KH; Lee SI; Kim SG; Park LC; Lee SC; Park BB; Ji JH; Yi SY; Lee YG; Yun J; Bruera E; Hwang IG; Kang JH
Oncologist; 2017 Nov; 22(11):1354-1361. PubMed ID: 28687626
[TBL] [Abstract][Full Text] [Related]
18. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
Hamadani M; Chaudhary L; Awan FT; Khan JK; Kojouri K; Ozer H; Tfayli A
J Oncol Pharm Pract; 2007 Jun; 13(2):69-75. PubMed ID: 17873106
[TBL] [Abstract][Full Text] [Related]
19. Risk Model-Guided Antiemetic Prophylaxis vs Physician's Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer: A Randomized Clinical Trial.
Clemons M; Bouganim N; Smith S; Mazzarello S; Vandermeer L; Segal R; Dent S; Gertler S; Song X; Wheatley-Price P; Dranitsaris G
JAMA Oncol; 2016 Feb; 2(2):225-31. PubMed ID: 26562292
[TBL] [Abstract][Full Text] [Related]
20. Induction of adrenal suppression by megestrol acetate in patients with AIDS.
Leinung MC; Liporace R; Miller CH
Ann Intern Med; 1995 Jun; 122(11):843-5. PubMed ID: 7741369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
